Environmental Engineer III
Boost your chances before you apply.
Alnylam Pharmaceuticals
US
Summary
Lead enterprise-wide corporate environmental sustainability strategy and manage ESG disclosure compliance. Conduct life cycle analysis of products and manage internal sustainability projects in collaboration with facilities and capital project teams.
Job Description
JOB TITLE: Senior Environmental - Sustainability Engineer
JOB DUTIES: Lead all aspects of enterprise-wide corporate environmental sustainability strategy, including collection, consolidation, maintenance, preparation and presentation of environmental sustainability reporting metrics, educational materials and aspects & impacts for Environmental, social, Governance (ESG) disclosure compliance. Conduct and drive Life Cycle Analysis of Alnylam products and process to quantify cargon impacts, energy use and overall environmental footprints. System owner/administrator of enterprise-wide sustainability software system. Project manage all internal sustainability projects, from conception to completion. Partner with Capital Projects, Facilities Engineering, and Facilities Operations to identify and quantify sustainability metrics (energy reduction, recycling, diversion) into projects in support of Alnylam’s goals. Lead cross-functional relationships and establish direct liasion with key Alnylam internal business partners and external stakeholders, such as building landlords and key suppliers, in support of Alnylam environmental/sustainability initiatives.
MINIMUM EDUCATION AND EXPERIENCE REQUIREMENTS: Master’s degree in Sustainability Science, Engineering (any) or related field of study and one (1) year of experience in the job offered or related occupation in which the required experience was gained. In lieu of a Master’s degree in Sustainability Science, Engineering (any) or related field of study and one (1) year of experience, the employer will also accept a Bachelor’s degree in Sustainability Science, Engineer (any) or related of study and three (3) years of experience in the job offered or related occupation in which the required experience was gained. Must have demonstrated experience with: Implementing and managing water, energy, hazardous waste and waste/recycling programs; Greenhouse gas calculation software systems; evaluating, recommending, implementing and being system owner of enterprise greenhouse gas calculation software systems; and EHS Management Systems (ISO 14001, 14064 and 45001).
OTHER: Employer: Alnylam US, Inc.
Job location: 675 W Kendall Street, Cambridge, MA 02142
40 hours/week; $132,724.69 - $145,600.00/Year (view contact information below)
If offered employment, must have legal right to work in U.S. EOE.
This notice is being posted as a result of the filing for a permanent resident labor certification application for this job opportunity. Any person may provide documentary evidence bearing on the application to:
U.S. Department of Labor
Employment and Training Administration
Office of Foreign Labor Certification
200 Constitution Avenue NW, Room N-5311
Washington, DC 20210
CONTACT: To apply, submit a resume to https://jobs.alnylam.com/careers?start=0&pid=893380660936&sort_by=hot, OR submit a resume to https://jobquest.dcs.eol.mass.gov/jobquest/LandingPage.aspx OR mail resume to: Alnylam US, Inc., Attn: HR, 675 West Kendall Street, Cambridge, MA 02142. Must reference Job Title & Job Code: [Requisition Number provided by Alnylam]. EOE.
SILENCE DISEASE. AMPLIFY LIFE.™
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.
Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.
We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work.
We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.
See our social media community guidelines: https://bit.ly/2FcRhJy.
Please note: If you wish to report an adverse event or product complaint, please email [email protected] or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861
Fraudulent Recruitment Activity
Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
Founded
2002
Company size
1,001-5,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Cambridge, Massachusetts
SILENCE DISEASE. AMPLIFY LIFE.™
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.
Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.
We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work.
We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.
See our social media community guidelines: https://bit.ly/2FcRhJy.
Please note: If you wish to report an adverse event or product complaint, please email [email protected] or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861
Fraudulent Recruitment Activity
Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
Founded
2002
Company size
1,001-5,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Cambridge, Massachusetts
